Patents for A61P 19 - Drugs for skeletal disorders (81,981)
08/1991
08/28/1991EP0443957A2 New 17-spiro substituted steroid compounds, process for their preparation and intermediates of this process, their use as medicines and pharmaceutical preparations containing them
08/27/1991US5043326 Inclusion complex of 7-isopropoxy-isoflavon formed with cyclodextrin, the preparation thereof and pharmaceutical compositions containing these compounds as active ingredients
08/23/1991CA2036847A1 Steroid products containing a spiro radical in position 17; process for preparing the same and intermediates for this process; their use as t erapeutic agents and
08/23/1991CA2036774A1 Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor and/or thromboxane receptorantagonist or a
08/14/1991EP0441036A2 Quinoline derivatives, processes for their preparation, intermediates, and pharmaceutical compositions containing these derivatives
08/07/1991EP0440183A1 Oxazole compounds, their production and use
08/06/1991US5037817 Crystallization from polar or apolar solvents; produces two crystalline pure forms; improved stability increases shelf-life
08/02/1991CA2035431A1 Oxazole compounds, their production and use
07/1991
07/30/1991US5036058 N-substituted aminoalkanediphosphonic acids
07/11/1991WO1991009601A1 Use of inositolphosphates for preparing medicament
07/11/1991WO1991009600A1 Oxipurinol salt composition for oral administration for treating hyperurecemia
07/10/1991EP0436469A1 Composition and method for the treatment of osteoporosis in mammals
07/03/1991EP0435362A1 Composition comprising non-steroidal anti-inflammatory agent and effectively non-antibacterial tetracycline
07/02/1991CA1285572C Di-t-butylphenol compounds
06/1991
06/28/1991WO1991009622A1 Radiolabeled colloid compositions, their use and process for their preparation
06/16/1991WO1991009036A1 Beta-lactam derivatives
06/16/1991CA2071885A1 Beta-lactam derivatives
06/13/1991WO1991007992A1 Proliferative action of leukaemia inhibitory factor on satellite cells
06/13/1991CA2045630A1 Proliferative action of leukaemia inhibitory factor on satellite cells
06/11/1991US5023261 Acylated benzofuro[3,2-c]quinoline compounds with utility as treatments for osteoporosis
06/04/1991US5021448 Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor inhibitor and/or thromboxane receptor antagonist
05/1991
05/29/1991EP0429038A2 Xanthine oxidase inhibitor
05/22/1991CN1012642B Process for preparation of sulfamoylbenzoic acid derivatives
05/07/1991US5013728 Composition for treating osteoporosis and hormonal imbalance
05/02/1991WO1991005802A1 Osteogenic devices
05/02/1991EP0424954A1 Pharmaceutical composition for treatment of osteoporosis
05/02/1991CA2042577A1 Osteogenic devices
04/1991
04/17/1991EP0422079A1 Tricyclic lipoxygenase inhibiting compounds, compositions, methods of use
04/16/1991US5008283 Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
04/09/1991CA1282702C Regimen for treating osteoporosis
04/02/1991US5004750 Benzofuran and benzothoiphene derivatives, of tetrazole and anti-hyperuricemia use thereof
03/1991
03/26/1991US5002968 Organogermanium compound, calcium metabolism
03/21/1991WO1990015586A3 Bioerodible polymers for drug delivery in bone
03/19/1991CA1281648C Remedy for bone disease containing organogermanium compound
03/13/1991EP0416689A2 Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors
03/13/1991EP0416578A2 Protein, DNA and use thereof
03/06/1991EP0415566A1 Heterocyclic compounds, processes for producing them and pharmaceutical compositions comprising them
03/06/1991CN1049664A Salts of optically active 4-hydroxy-8-(3-lower alkoxy-4-phenylsulfinylphenyl) pyrazolo (1,5-a)-1,3,5-triazines
02/1991
02/27/1991EP0414200A2 Salts of optically active 4-hydroxy-8-(3-lower alkoxy-4-phenylsulfinylphenyl)pyrazolo [1,5-a]-1,3,5-triazines and a process for production thereof
02/05/1991CA1279872C Cycloalkyl diphosphonic acid compounds and pharmaceutically-acceptable salts and esters thereof
02/04/1991CA2021926A1 Heterocyclic compounds
01/1991
01/31/1991DE4020511A1 Medicaments for treating e.g. hypercalcaemia - contg. 24,25-di:hydroxy-cholecalciferol together with sesame oil for improved stability
01/15/1991US4985444 Pyrazolopyridine compound and processes for preparation thereof
01/09/1991EP0406279A1 Pharmaceutical preparation containing a fluoride salt
12/1990
12/19/1990EP0403185A2 Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals
12/13/1990DE3922089A1 Neue proteine und ihre herstellung New proteins and their production
12/12/1990CA2018700A1 Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals
12/06/1990WO1990015586A2 Bioerodible polymers for drug delivery in bone
12/05/1990EP0400499A2 Medicine containing acylaminoacid derivatives and dietetic products
12/04/1990CA1277233C Kit for use in the treatment of osteoporosis
12/03/1990WO1990014829A1 Lysolecithin derivatives for treating autoimmune diseases
11/1990
11/27/1990US4973584 Osteoporosis
11/15/1990WO1990013575A1 Novel tnf-inhibit proteins and their preparation
11/15/1990WO1990013292A1 Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis
11/15/1990CA2425101A1 Tnf-inhibiting proteins and the preparation thereof
10/1990
10/31/1990EP0395093A1 Triphenylmethane derivatives
10/31/1990EP0394429A1 Preparation for transdermal application containing gestodene.
10/31/1990CN1046525A 3-substituted-2-oxindole derivatives
10/24/1990EP0393936A1 3-substituted-2-oxindole derivatives as antiinflammatory agents
10/03/1990EP0389765A1 Calcium antagonists
09/1990
09/26/1990EP0389035A1 Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
09/20/1990WO1990010619A1 NOVEL 1α-HYDROXYVITAMIN D2 EPIMER AND DERIVATIVES
09/12/1990EP0387194A1 N-substituted aminoalkane-diphosphonic acids
09/12/1990EP0386793A1 Novel 1 alpha-Hydroxyvitamin D2 epimer and derivatives
09/12/1990EP0386109A1 Acceleration of bone formation with gm-csf
09/08/1990WO1990010454A1 Metabolic effects of leukaemia inhibitory factor on bone
09/08/1990CA2048673A1 Metabolic effects of leukaemia inhibitory factor on bone
09/08/1990CA2011586A1 N-substituted aminoalkanediphosphonic acids
09/05/1990CN1045106A Sulfur-containing heterocyclic compounds
09/02/1990WO1990010228A1 Matrix metalloproteinase peptides: role in diagnosis and therapy
08/1990
08/29/1990EP0384731A2 Osteogenic growth polypeptides identified from regenerating bone marrow
08/28/1990WO1990010631A1 9-substituted-8-unsubstituted-9-deazaguanines
08/23/1990WO1990006313A3 Alkali and alkaline earth salts of oxypurinol in amorphous or crystalline form as agents for treating hyperuricemia and gout
08/23/1990WO1990006115A3 Preparations of oxypurinol and/or its alkali or alkaline earth salts
08/23/1990CA2010660A1 Osteogenic growth polypeptides identified from regenerating bone marrow
08/22/1990CN1044813A Calcium antagonists
08/16/1990EP0382076A1 Phenylhydrazones, their preparation and medicaments and cosmetics manufactured therefrom
08/16/1990DE4003844A1 Neue cyclosporin enthaltende galenische formulierungen New cyclosporin-containing pharmaceutical formulations
08/15/1990CN1044656A Pyrazolopyridine compound and processes for preparation thereof
08/08/1990EP0381296A1 Kit for use in the treatment of osteoporosis
08/01/1990EP0379979A1 Pyrazolopyridine compounds and processes for preparation thereof
07/1990
07/26/1990WO1990007861A1 CHIMERIC IMMUNOGLOBULINS SPECIFIC FOR p55 TAC PROTEIN OF THE IL-2 RECEPTOR
07/18/1990CN1043875A Novel 1 l-2 receptor-specific human immunoglobins
07/04/1990EP0376197A1 Sulfur-containing heterocyclic compounds
07/03/1990US4939131 Certain cycloalkane-1,1-diphosphonic acids and derivatives thereof having the ability to treat diseases associated with abnormal calcium and phosphate metabolism
06/1990
06/28/1990WO1990006950A1 Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
06/27/1990EP0375438A2 Recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
06/14/1990WO1990006313A2 Alkali and alkaline earth salts of oxypurinol in amorphous or crystalline form as agents for treating hyperuricemia and gout
06/14/1990WO1990006115A2 Preparations of oxypurinol and/or its alkali or alkaline earth salts
06/13/1990DE3839825A1 Feststoffdispersionen enthaltend oxipurinol und/oder seine alkali- oder erdalkalisalze Solid dispersions containing alkaline earth oxypurinol and / or its alkali metal or alkaline
06/12/1990US4933329 Bis-S-alkylbenzene derivatives
06/05/1990US4931548 Heterodimer form of transforming growth factor-beta
05/1990
05/31/1990DE3839826A1 Alkali- und erdalkalisalze des oxipurinols in amorpher oder kristalliner form als mittel zur behandlung von hyperurikaemie und gicht Alkali metal and alkaline earth metal salts of oxypurinol in amorphous or crystalline form as a means for the treatment of hyperuricemia and gout
05/30/1990EP0370220A1 Gestode composition for transdermal application
05/16/1990CN1042075A Medicines for transcortical application containing steroidhormonen
05/03/1990WO1990004403A1 Treatment of hypertension
05/03/1990WO1990004402A1 Treatment of osteoporosis
05/03/1990WO1990004397A1 Preparation for transdermal application containing gestodene
05/01/1990US4921697 IFN-gamma as an active substance for inhibiting and preventing degradation processes in bone
04/1990
04/25/1990EP0365064A1 Substituted aromatic compounds having an action on the central nervous system